Skip to Content

Demand Brands Inc DMAN

Morningstar Rating
$0.00 0.00 (18.18%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

DMAN is trading at a 57% discount.
Price
$0.00
Fair Value
$4.68
Uncertainty
Extreme
1-Star Price
$4.76
5-Star Price
$3.58
Economic Moat
Zftm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DMAN is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$1.25 Mil
Volume/Avg
100 / 1.0 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Demand Brands Inc is engaged in the business of developing opportunities in marketing, cultivating, developing and distributing cannabis and related products. The Company provides value and solutions through service contracts to cannabis businesses consisting of several, vertically integrated cannabis-related operating units including cultivation, processing, brand management as well as both wholesale and retail distribution.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees
3

Valuation

Metric
DMAN
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
DMAN

Financial Strength

Metric
DMAN
Quick Ratio
1.39
Current Ratio
1.39
Interest Coverage
Quick Ratio
DMAN

Profitability

Metric
DMAN
Return on Assets (Normalized)
0.34%
Return on Equity (Normalized)
0.41%
Return on Invested Capital (Normalized)
0.40%
Return on Assets
DMAN
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRQwffzwpfyZyzrlyd$70.9 Bil
ZTS
Zoetis Inc Class ASdttzgntkPqcj$68.3 Bil
HLN
Haleon PLC ADRTbnvstpqpMng$37.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRByrrtscYvwg$14.7 Bil
VTRS
Viatris IncZbsylxkbYcnz$13.7 Bil
RDY
Dr Reddy's Laboratories Ltd ADRWyldkfhmPymxr$11.9 Bil
CTLT
Catalent IncYgpbcdmkGqjnxn$10.1 Bil
PRGO
Perrigo Co PLCSbbdhpjLxp$4.1 Bil
CURLF
Curaleaf Holdings IncMdvcqmjqXdff$3.6 Bil
PBH
Prestige Consumer Healthcare IncHtpztqgyJhjlqc$3.5 Bil

Sponsor Center